News | September 26, 2023
Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
The product is expected to start contributing meaningfully to the revenue from FY25
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Subscribe To Our Newsletter & Stay Updated
